Compassionate Care for LGBTQ+ Individuals Struggling with Substance Use Disorder

Compassionate Care for LGBTQ+ Individuals Struggling with Substance Use Disorder

Research suggests that LGBTQ adults have higher rates of substance use and mental health issues, compared to their heterosexual cisgender peers. These health disparities are often related to minority stress—the chronic psychological and emotional strain that people experience due to being part of a marginalized social group. For example, some LGBTQ folks may use alcohol and drugs to cope with internalized homophobia or to self-medicate for anxiety and depression. On the other hand, some people use drugs in the context of social settings and connecting with others in their community. Since not all substance use is unhealthy, how do providers know how to identify when substance use is problematic? And what can physicians do to best support their patients who may be at greater risk for harm or even overdose?

On this episode, Antonio Urbina, MD, Medical Director for CEI’s HIV Primary Care and Prevention Center of Excellence, speaks with Eric Kutscher, MD, MSc. Dr. Eric Kutscher is an Assistant Professor of Medicine at the Icahn School of Medicine, where he practices as a primary care and addiction medicine physician at Mount Sinai's Internal Medicine Associates and REACH Program. He currently serves as the Medical Director of the Mount Sinai Hospital Opioid Overdose Prevention Program and Primary Care Lead for the Mount Sinai Center for Transgender Medicine and Surgery. His clinical work and research focus on harm reduction techniques for patients with substance use disorders, particularly within the LGBTQ+ community. Drs. Urbina and Kutscher talk about how providers can identify when substance use is a problem and how to help patients manage substance use disorder, including treatment options and harm reduction strategies. Related Content:

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(74)

Three New Two-Drug Regimens: Which Problem Does Each One Solve?

Three New Two-Drug Regimens: Which Problem Does Each One Solve?

In this episode, Dr. Antonio E. Urbina, Medical Director for CEI’s HIV Primary Care and Prevention Center of Excellence, provides an overview of three new two-drug regimens: daily doravirine/islatravi...

22 Okt 18min

Ditching the Script: Person-Centered Contraceptive Counseling

Ditching the Script: Person-Centered Contraceptive Counseling

Erica Bostick, MD is joined by guest speaker Susan Wiener, MD, MPH for this episode of “Conversations with CEI.” Dr. Susan Wiener is an Assistant Professor of Pediatrics in the Division of Adolescent ...

6 Okt 25min

Anabolic Androgenic Steroids: Is “The Cycle” Addictive?

Anabolic Androgenic Steroids: Is “The Cycle” Addictive?

Anabolic androgenic steroids (AAS) are synthetic versions of testosterone, and like naturally produced testosterone, they can increase male sex characteristics and help build muscle. They are prescrib...

24 Sep 21min

AIDS 2026 in Rio: What Came Out of the 26th International AIDS Conference

AIDS 2026 in Rio: What Came Out of the 26th International AIDS Conference

AIDS 2026, the 26th International AIDS Conference, was held on July 26-31 in Rio. In this episode, Dr. Antonio E. Urbina, Medical Director for CEI’s HIV Primary Care and Prevention Center of Excellenc...

10 Sep 17min

Updates on HSV Infection

Updates on HSV Infection

Daniela DiMarco, MD, MPH is joined by guest speaker Valeria Cantos, MD for this episode of “Conversations with CEI.” Dr. Valeria Cantos is an Associate Professor at the Division of Infectious Diseases...

27 Aug 22min

Beyond the Script: Applying Harm Reduction Principles in Practice

Beyond the Script: Applying Harm Reduction Principles in Practice

Communication and relationship building are key approaches to harm reduction that focus on meeting people where they are. Both rely on shifting away from stigma and bias to create a safe, open dialogu...

13 Aug 46min

Cardiovascular Risk in People with HIV: New Risk Equations, New Guidelines, and Who Gets a Statin

Cardiovascular Risk in People with HIV: New Risk Equations, New Guidelines, and Who Gets a Statin

The 2026 ACC/AHA/Multisociety Dyslipidemia Guideline recommends statin therapy for primary prevention of ASCVD for all people living with HIV (PLHIV) aged 40 to 75 years, independently of their tradit...

23 Juli 17min

Best of the Best: Practice-Changing Papers in STI Care from 2025

Best of the Best: Practice-Changing Papers in STI Care from 2025

Hosts Margie Urban, MD, and Daniela DiMarco, MD, MPH, are joined by Jason Zucker, MD. Dr. Zucker is an Assistant Professor of Medicine at the Columbia University Irving Medical Center and is also the ...

9 Juli 21min

Populärt inom Utbildning

husmodern-med-amanda-schulman
rss-bara-en-till-om-beroende-medberoende
historiepodden-se
det-skaver
nu-blir-det-historia
rosceremoni
sektledare
rss-dr-bjorklund
harrisons-dramatiska-historia
not-fanny-anymore
rss-viktmedicinpodden
roda-vita-rosen
allt-du-velat-veta
johannes-hansen-podcast
sa-in-i-sjalen
i-vantan-pa-katastrofen
rss-max-tant-med-max-villman
rss-foraldramotet-bring-lagercrantz
kan-jag-sa-kan-du-podden
rss-traningsklubben